BRAF (V600E), GST-His-Tag Recombinant
Catalog #
40533
$355
*
●
●
Purchase
Description
Recombinant human BRAF (B-Raf proto-oncogene, serine/threonine kinase), encompassing amino acids 417-766(end) containing the mutation of interest (V600E). This construct contains an N-terminal GST-tag followed by a His-tag (6His). A Thrombin Cleavage Site to facilitate removal of the GST portion is also present between the His portion and the protein. The recombinant protein was affinity purified.
●
Synonyms
BRAF1, RAFB1, B-raf 1, MGC126806, MGC138284, BRAF (V600E)
●
Product Data Gallery
Product Info
Storage and Usage
Citations
Species
Human
Construct
BRAF (V600E) (GST-His-417-766(end))
Host Species/Expression System
Sf9
Purity
≥79%
Format
Aqueous buffer solution
Formulation
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 0.04% Tween-20, 20% glycerol, and 3 mM DTT
MW
69 kDa
Amino Acids
417-766(end)
Specific Activity
166 pmol/min/μg
Genbank #
NM_004333
UniProt #
P15056
Background
BRAF is a member of the RAF family that is activated by members of the Ras family upon growth factor-induced stimulation. Active Ras can induce heterodimerization of cRaf and BRAF and this may explain the observed cooperativity of cRaf and BRaf in cells responding to growth factor signals (1). Activating mutations in the BRAF gene are present in a large percentage of human malignant melanomas and in a proportion of colon cancers. The vast majority of these mutations result in a valine to glutamic acid change at residue 600 within the activation segment of B-RAF (2).
References
1. Weber, C.K., et al., Cancer Res. 2001 May 1, 61(9): 3595-8.
2. Mercer, K.E., et al., Biochim Biophys Acta. 2003 Jun 5, 653(1): 25-40.
2. Mercer, K.E., et al., Biochim Biophys Acta. 2003 Jun 5, 653(1): 25-40.